XL019
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | XL019 is an orally bioavailable inhibitor of Janus-associated kinase 2 (JAK2) with potential antineoplastic activity. | ||
---|---|---|---|
Targets |
|
Catalog Num | A12394 |
---|---|
Formula | C25H28N6O2 |
Molecular Weight | 444.53 |
CAS Number | 945755-56-6 |
SMILES | C1C[C@H](NC1)C(=O)NC2=CC=C(C=C2)C3=NC(=NC=C3)NC4=CC=C(C=C4)N5CCOCC5 |
Synonyms | XL 019, XL-019 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 14 mg/mL (31.49 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 22.5 mL | 112.48 mL | 224.96 mL |
0.5 mM | 4.5 mL | 22.5 mL | 44.99 mL |
1 mM | 2.25 mL | 11.25 mL | 22.5 mL |
5 mM | 0.45 mL | 2.25 mL | 4.5 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2